G-Neobacitracin Topical Powder (5 mg+250 IU)/gm

G-Neobacitracin Topical Powder (5 mg+250 IU)/gm Uses, Dosage, Side Effects, Food Interaction and all others data.

Bacitracin inhibits bacterial cell wall synthesis and is active against many gram-positive bacteria (e.g. staphylococci, streptococci, corynebacteria and Clostridia) and some gram-negative species (e.g. Neisseria and Haemophilus influenzae). They are often found in combinations in topical preparations as broad spectrum antibacterial agents.

Neomycin, an aminoglyoside with antimicrobial spectrum similar to gentamicin, binds to the 30S subunits of the bacterial ribosome, inhibiting protein synthesis and thereby disrupting DNA synthesis. It is active against many gram negative aerobes and against some strains of staphylococci.

G-Neobacitracin Topical Powder (5 mg+250 IU)/gm
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	G-Neobacitracin Topical Powder (5 mg+250 IU)/gm
Generic	Neomycin Sulfate + Bacitracin Zinc
Weight	(5 mg+250 IU)/gm
Type	Topical Powder
Therapeutic Class	Ophthalmic and Topical antibacterial products
Manufacturer	Gonoshasthaya Pharma Ltd.
Available Country	Bangladesh
Last Updated:	October 19, 2023 at 6:27 am

G-Neobacitracin Topical Powder (5 mg+250 IU)/gm

Uses

This is used for furunculosis, impetigo, sycosis barbae, eczema, skin ulcer, infected wounds, infected burn wounds, strains of Staphylococci which are resistant to other antibiotics usually remain sensitive to Bacitracin.

Dosage

G-Neobacitracin Topical Powder (5 mg+250 IU)/gm dosage

Skin/Eye Ointment: Apply two to three times daily to the affected skin area.

Dusting Powder: Antibiotic powder is a non- sterile dusting powder and used for superficial skin infections. A light dusting of the powder to be applied to the affected skin area upto 4 times daily.

Side Effects

G-Neobacitracin Topical Powder (5 mg+250 IU)/gm is usually well tolerated. In rare cases, allergic reactions may be occurred.

Precaution

Bacitracin & Neomycin antibiotic powder should not be used to large open wounds or to severely injured skin or on areas that exude large volumes of fluid as hard crusts may form. Since this skin ointment contains Neomycin, it should not be used for the treatment of otitis external when the eardrum is perforated because of risk of ototoxicity.

Patients considering self-medication with a topical anti-infective for deep or puncture wounds, animal bites, or serious burns should be advised to first consult a physician. Patients using the preparations for the prevention of infection in minor skin injuries (e.g., cuts, scrapes, burns) should be advised to discontinue the topical anti-infective preparation and consult a physician if the condition persists or worsens; it should not be used for longer than 1 week unless directed by a physician.

Interaction

Bacitracin Zinc: Increased risk of nephrotoxicity when used with other nephrotoxic drugs. May enhance the action of neuromuscular-blocking agents.

Neomycin Sulphate: Additive nephrotoxic and neurotoxic effect with other aminoglycosides, bacitracin, cisplatin, vancomycin, amphotericin B, polymyxin B, colistin and viomycin. Enhanced toxicity with potent diuretics. May impair the absorption of other drugs. May enhance the effect of acarbose. May enhance the effect of non-depolarising muscle relaxants. May antagonise the parasympathomimetic effect of neostigmine and pyridostigmine. May increase the risk of hypocalcaemia in patients receiving bisphosphonates. May alter INR when givenwithanticoagulants. May inactivate oral typhoid vaccine.

Pregnancy & Breastfeeding use

The safe use of G-Neobacitracin Topical Powder (5 mg+250 IU)/gm during pregnancy & lactation has not been established. Therefore it should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Contraindication

Hypersensitivity to any of its components.

Special Warning

Children and Infants: This ointment is suitable for use in children at the same dose as adults, but the dose should be reduced in infants. This ointment is not recommended for use in neonates.